Company intelligence / Profile preview

Primerdesign

Eastleigh/Southampton, England, United Kingdomprimerdesign.co.uk ↗

Ownership: Private
Employees: ~21
Development stage: Commercial

Overview

Primerdesign has a strong track record in rapid response to emerging infectious disease outbreaks with the world's first commercial detection kits for both H1N1 swine flu and H7N9 bird flu. The company also played a central role during the horse meat contamination scandal by providing animal speciation DNA tests. Its products are widely used globally across clinical diagnostics, food safety testing, veterinary health, and research settings. No clinical trial results apply as it operates in the diagnostic/device sector rather than drug development.

Therapeutic areas: OtherInfectious Diseases
Modalities: DeviceDiagnostic kitSynthetic oligonucleotideReagent
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Primerdesign.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Primerdesign.

Explore the full profile